Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5999-14-4

Post Buying Request

5999-14-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5999-14-4 Usage

Molecular Structure

A heterocyclic compound consisting of two benzimidazole rings connected by a methylene bridge.

Molecular Weight

264.31 g/mol

Physical State

Solid

Appearance

White or off-white crystalline powder

Solubility

Slightly soluble in water, soluble in organic solvents like DMSO and ethanol.

Biological Activity

Selective inhibitor of the protein kinase CK1, which plays a role in regulating cellular processes such as cell division and cell cycle progression.

Anti-Cancer Properties

Shows promising results in inhibiting the growth of cancer cells and inducing apoptosis in vitro.

Other Therapeutic Effects

Anti-inflammatory and anti-viral effects.

Potential Applications

Cancer treatment and other therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 5999-14-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,9,9 and 9 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 5999-14:
(6*5)+(5*9)+(4*9)+(3*9)+(2*1)+(1*4)=144
144 % 10 = 4
So 5999-14-4 is a valid CAS Registry Number.
InChI:InChI=1/C17H26N2O3S/c1-22-16-7-9-17(10-8-16)23(20,21)19-13-11-18(12-14-19)15-5-3-2-4-6-15/h7-10,15H,2-6,11-14H2,1H3

5999-14-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(1H-benzimidazol-2-ylmethyl)-1H-benzimidazole

1.2 Other means of identification

Product number -
Other names bis(1H-benzimidazol-2-yl)-methane

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5999-14-4 SDS

5999-14-4Relevant articles and documents

-

Arnold et al.

, p. 565,567 (1958)

-

Polymerization and copolymerization of olefins and acrylates by bis(benzimidazole) copper catalysts

Stibrany, Robert T.,Schulz, Donald N.,Kacker, Smita,Patil, Abhimanyu O.,Baugh, Lisa S.,Rucker, Steven P.,Zushma, Stephen,Berluche, Enock,Sissano, Joseph A.

, p. 8584 - 8586 (2003)

CuBBIM/MAO is a highly versatile catalyst system that homopolymerizes ethylene and acrylates and, more significantly, induces ethylene/acrylate copolymerization. This new system is remarkable in spanning homopolymerization space broadly, while still enabling copolymerization of these traditionally transition-metal-catalyzed incompatible monomer classes.

Head-to-head bisbenzazole derivatives as antiproliferative agents: design, synthesis, in vitro activity, and SAR analysis

Ersan, Ronak Haj,Alagoz, Mehmet Abdullah,Ertan-Bolelli, Tugba,Duran, Nizami,Burmaoglu, Serdar,Algul, Oztekin

, p. 2247 - 2259 (2020/06/27)

Abstract: In the present work, a series of bisbenzazole derivatives were designed and synthesized as antiproliferative agents. The antiproliferative activity of these compounds was investigated using MTT assay. Bisbenzazole derivatives showed significant antiproliferative activity against all the four tested cancer cell lines. Among the various bisbenzazole derivatives, bisbenzoxazole derivatives exhibited the most promising anticancer activity followed by bisbenzimidazole and bisbenzothiazole derivatives. All the derivatives were found to be less toxic as compared to methotrexate (positive control) in normal human cells, indicating selective and efficient antiproliferative activity of these bisbenzazole derivatives. The structure–activity relationships of heteroaromatic systems and linkers present in bisbenzazole derivatives were analyzed in detail. In silico ADMET prediction revealed that bisbenzazole is a drug-like small molecule with a favorable safety profile. Compound 31 is a potential antiproliferative hit compound that exhibits unique cytotoxic activity distinct from methotrexate. Graphic abstract: Twenty-one bisbenzoxazole derivatives have been designed synthesized and evaluated to be an antiproliferative activity against four human tumor cell lines.[Figure not available: see fulltext.]

An efficient synthesis of novel di-heterocyclic benzazole derivatives and evaluation of their antiproliferative activities

Algul, Oztekin,Ersan, Ronak Haj,Alagoz, Mehmet Abdullah,Duran, Nizami,Burmaoglu, Serdar

, p. 6926 - 6938 (2020/08/13)

A series of unsymmetrical nine di-heterocyclic compounds of benzazole derivatives were synthesized at one step via cyclization reaction. The compounds evaluated for in?vitro cytotoxic activity against A549, A498, HeLa, and HepG2 cancer cell lines. The biological evaluation results show that 23, 26 and 29 exhibit better activity against HepG2 and HeLa cancer cell lines. Compound 23 also showed good activity against A549, and A498 cancer cell lines. The analogs were further performed molecular docking studies against human cytochrome P450 2C8 monooxygenase enzyme, calculated some theoretical quantum parameters, ADMET descriptor and molecular electrostatic potential analysis. The strategy applied in this research work may act as a perspective for the rational design of potential anticancer drugs. Communicated by Ramaswamy H. Sarma.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5999-14-4